A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)
Clinical trial NCT05487170 · RECRUITING
Trial details
- NCT number
- NCT05487170
- Sponsor
- Ranok Therapeutics (Hangzhou) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-12
- Primary completion
- 2025-06-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.